(Press-News.org) Philadelphia, Pa. – The texture of breast cancer tissue differs from that of healthy tissue. Using a cutting-edge tissue diagnostic device, a group of researchers in Basel, Switzerland, has determined one key difference: cancerous tissue is a mix of stiff and soft zones, whereas healthy tissue has uniform stiffness. This new finding may one day help improve breast cancer diagnosis and therapy by providing a unique nanomechanical signature of tumor tissue properties that indicates the potential for the cancer to spread. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.
"It is slowly being recognized that a key to the cancer problem lies in the physical properties of the tumor tissue and that biomechanics plays a key role in cancer cell migration, invasion, and metastasis," explains Marija Plodinec of the University of Basel in Switzerland. However, contradictory opinions persist about tissue texture, and the information is hard to get at – cellular mechanics happen at the nanoscale, 1-100 millionths of a meter. This research may help resolve the controversy.
To determine stiffness, the team applied a nanoscale microscope tip to a breast tissue biopsy to make an indentation, then visualized and measured the indentation with an indentation-type atomic force microscope, which provides unprecedented spatial resolution. "The most significant outcome of our measurements is determining that in healthy tissue the stiffness of the sample is homogeneous," Plodinec says. "Benign tissue exhibits a larger variability and malignant tissue shows a unique, very heterogeneous profile with soft and stiff parts alternating."
A key aspect of their experiment is the adaptation of atomic force microscopy to rapidly collect and correlate nanoscale stiffness measurements across entire biopsy samples. They used a device called ARTIDIS ("Automated and Reliable Tissue Diagnostics"), invented by Plodinec and colleagues Marko Loparic and Roderick Lim. Partnering with industry, their next step is to develop ARTIDIS into an easy-to-use device for clinical application, hopefully within two years.
"A critical advantage of ARTIDIS technology, as we see it, is that it provides an estimate of tumor aggressiveness and metastatic spread based on the unique nanomechanical signature," Plodinec says. "This signature may have potential prognostic and predictive value as a marker for therapeutic applications."
###
Presentation #1639-Pos, "The nanomechanical signature of breast cancer," will take place at 1:45 p.m. on Monday, Feb. 4, 2013, in the Pennsylvania Convention Center, Hall C. ABSTRACT: http://tinyurl.com/b2edbq6
This news release was prepared for the Biophysical Society (BPS) by the American Institute of Physics (AIP).
ABOUT THE 2013 ANNUAL MEETING
Each year, the Biophysical Society Annual Meeting brings together over 6,000 research scientists in the multidisciplinary fields representing biophysics. With more than 3,900 poster presentations, over 200 exhibits, and more than 20 symposia, the Annual Meeting is the largest meeting of biophysicists in the world. Despite its size, the meeting retains its small-meeting flavor through its subgroup meetings, platform sessions, social activities, and committee programs.
The 57th Annual Meeting will be held at the Pennsylvania Convention Center (1101 Arch Street, Philadelphia, PA 19107). For maps and directions, please visit: http://www.paconvention.com/explore-philadelphia/directions-and-parking.
QUICK LINKS
Meeting Home Page:
http://www.biophysics.org/2013meeting/Main/tabid/3523/Default.aspx
Housing and Travel Information:
http://www.biophysics.org/2013meeting/AccommodationsTravel/HotelInformation/tabid/3621/Default.aspx
Program Abstracts and Itinerary Planner:
http://www.abstractsonline.com/plan/start.aspx?mkey=%7B763246BB-EBE4-430F-9545-81BC84D0C68C%7D
PRESS REGISTRATION
The Biophysical Society invites credentialed journalists, freelance reporters working on assignment, and public information officers to attend its Annual Meeting free of charge. For more information on registering as a member of the press, contact BPS Director of Public Affairs and Communications Ellen Weiss at eweiss@biophysics.org or 240-290-5606, or visit
http://www.biophysics.org/2013meeting/Registration/Press/tabid/3619/Default.aspx. Press registration will also be available onsite at the Pennsylvania Convention Center in the Biophysical Society's meeting office, Room 304VIP.
ABOUT BPS
The Biophysical Society (BPS), founded in 1958, is a professional scientific society established to encourage development and dissemination of knowledge in biophysics. The Society promotes growth in this expanding field through its annual meeting, monthly journal, and committee and outreach activities. Its 9000 members are located throughout the U.S. and the world, where they teach and conduct research in colleges, universities, laboratories, government agencies, and industry. For more information on the Society or the 2013 Annual Meeting, visit www.biophysics.org.
For more information, please contact:
Ellen R. Weiss
Director of Public Affairs and Communications
eweiss@biophysics.org
240-290-5606 END
The nanomechanical signature of breast cancer
Differences in tissue stiffness have potential to aid in diagnosis, therapy
2013-02-02
ELSE PRESS RELEASES FROM THIS DATE:
Type II diabetes and the Alzheimer's connection
2013-02-02
Philadelphia, Pa. – A research team in Israel has devised a novel approach to identifying the molecular basis for designing a drug that might one day decrease the risk diabetes patients face of developing Alzheimer's disease. The team will present its work at the 57th Annual Meeting of the Biophysical Society (BPS), held Feb. 2-6, 2013, in Philadelphia, Pa.
A recent study suggests that people who suffer from type 2 diabetes face twice the risk of developing Alzheimer's disease later in life compared to those who do not have diabetes. The link these diseases share relates ...
Cooperators can coexist with cheaters, as long as there is room to grow
2013-02-02
Philadelphia, Pa. – Microbes exhibit bewildering diversity even in relatively tight living quarters. But when a population is a mix of cooperators, microbes that share resources, and cheaters, those that selfishly take yet give nothing back, the natural outcome is perpetual war. A new model by a team of researchers from Princeton University in New Jersey and Ben-Gurion University in Israel reveals that even with never-ending battles, the exploiter and the exploited can survive, but only if they have room to expand and grow. The researchers present their findings at the ...
Tracking the evolution of antibiotic resistance
2013-02-02
Philadelphia, Pa. – With the discovery of antibiotics, medicine acquired power on a scale never before possible to protect health, save lives, and reduce suffering caused by certain bacteria. But the power of antibiotics is now under siege because some virulent infections no longer respond to antibiotic drugs.
This antibiotic resistance is an urgent public health threat that a team of researchers from Sabanci University in Istanbul, Turkey, and Harvard Medical School and Harvard University in Cambridge, Mass., aim to stop. Their approach is based on an automated device ...
Propping open the door to the blood brain barrier
2013-02-02
Philadelphia, Pa. – The treatment of central nervous system (CNS) diseases can be particularly challenging because many of the therapeutic agents such as recombinant proteins and gene medicines are not easily transported across the blood-brain barrier (BBB). Focused ultrasound can be used to "open the door" of the blood brain barrier. However, finding a way to "prop the door open" to allow therapeutics to reach diseased tissue without damaging normal brain tissue is the focus of a new study by a team of researchers at the Institute of Biomedical Engineering at National ...
Quantum dots deliver Vitamin D to tumors for possible inflammatory breast cancer treatment
2013-02-02
Philadelphia, Pa. – The shortened daylight of a Maine winter may make for long, dark nights – but it has shone a light on a novel experimental approach to fighting inflammatory breast cancer (IBC), an especially deadly form of breast cancer.
The new approach enlists the active form of Vitamin D3, called calcitriol, which is delivered therapeutically by quantum dots. Quantum dots are an engineered light-emitting nanoscale delivery vehicle. This new preliminary work shows the dots can be used to rapidly move high concentrations of calcitriol to targeted tumor sites where ...
New methods for quantifying antisense drug delivery to target cells and tissues
2013-02-02
New Rochelle, NY, January 31, 2012—Powerful antisense drugs that target disease-associated genes to block their expression can be used to treat a broad range of diseases. Though antisense therapy has been proven effective, challenges remain in ensuring that the drugs reach their intended targets. Two new methods for detecting and measuring the levels of antisense drugs in cells that could accelerate the development of improved antisense drugs are described in an article in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc., ...
Trauma patients, community say they support exception from informed consent research
2013-02-02
PHILADELPHIA — Traumatic injury – including car accidents, gunshot wounds, and stabbings – is the leading cause of death for people younger than 40 years old in the United States, but despite the toll of these injuries, few emergency medical interventions considered to be the standard of care for these injuries have been rigorously studied in clinical trials, because patients and their families are typically unable to consent to participate in research. A new study from the Perelman School of Medicine at the University of Pennsylvania sought to examine peoples' willingness ...
Moffitt Cancer Center researchers develop automated breast density test linked to cancer risk
2013-02-02
Researchers at Moffitt Cancer Center and colleagues at the Mayo Clinic in Rochester, Minn., have developed a novel computer algorithm to easily quantify a major risk factor for breast cancer based on analysis of a screening mammogram. Increased levels of mammographic breast density have been shown in multiple studies to be correlated with elevated risk of breast cancer, but the approach to quantifying it has been limited to the laboratory setting where measurement requires highly skilled technicians. This new discovery opens the door for translation to the clinic where ...
Inaugural issue of the NYU College of Dentistry's JADE online now
2013-02-02
New York University College of Dentistry (NYUCD) is delighted to introduce the inaugural issue of the Journal of the Academy of Distinguished Educators (JADE), published by NYUCD. JADE can be accessed by going to http://www.nyu.edu/dental/ade/.
An online-only, open-access journal, JADE is the publications component of the NYU Academy of Distinguished Educators. The mission of the Academy is to enhance overall teaching at NYUCD and to stimulate excitement among teachers around their intellectual content.
JADE intends to invite experts in higher education to face off ...
Humanitarian aid workers in Uganda show signs of stress, depression, and burnout
2013-02-02
Latest research points to the high risk for mental health problems among staff working in humanitarian organizations in northern Uganda, due in large part to their work environment. A new study by researchers at Columbia's Mailman School of Public Health examined the mental health of 376 Ugandan workers at 21 humanitarian aid agencies and found that a significant number of the staff at these organizations experienced high levels of symptoms for depression (68%), anxiety disorders (53%), and posttraumatic stress disorder (PTSD) (26%), respectively.
Research up to now ...
LAST 30 PRESS RELEASES:
Medication decisions in pregnancy: A balancing act
Texas Tech researcher named Station Science Leader for Antarctica project
Restricting sugar consumption in utero and in early childhood significantly reduces risk of midlife chronic disease
Apixaban vs aspirin in patients with cancer and cryptogenic stroke
Can magnetic pulses aimed at the brain treat insomnia?
F.M. Kirby Research Center honors 25 years of pioneering brain imaging research
$1.75M CDC grant funds study to boost vaccine acceptance in Arizona’s rural, border communities
Immune system review provides insight into more effective biotechnology
Remote control eddies: Upwelled nutrients boost productivity around Hawaiian Islands
Rice, Texas Medical Center institutions jointly award seed grants
Sleeping for 2: Insomnia therapy reduces postpartum depression, study shows
How fruit flies achieve accurate visual behavior despite changing light conditions
First blueprint of the human spliceosome revealed
The harmful frequency and reach of unhealthy foods on social media
Autistic traits shape how we explore
UCLA chemists just broke a 100-year-old rule and say it’s time to rewrite the textbooks
Uncovered: the molecular basis of colorful parrot plumage
Echolocating bats use acoustic mental maps to navigate long distances
Sugar rationing in early life lowers risk for chronic disease in adulthood, post-World War II data shows
Indigenous population expansion and cultural burning reduced shrub cover that fuels megafires in Australia
Echolocating bats use an acoustic cognitive map for navigation
Researchers solve medical mystery of neurological symptoms in kids
Finding a missing piece for neurodegenerative disease research
Journal of the Royal Society of Medicine ranked in global top ten medical journals
A new piece in the grass pea puzzle - updated genome sequence published
“Wearable” devices for cells
Cancer management: Stent sensor can warn of blockages in the bile duct
Nov. 14 AARP Author Q&A at GSA 2024 in Seattle: Debra Whitman, Global Aging Expert and Author of ‘The Second Fifty: Answers to the 7 Big Questions of Midlife and Beyond’
Autistic psychiatrists who don't know they're autistic may fail to spot autism in patients
New findings on animal viruses with potential to infect humans
[Press-News.org] The nanomechanical signature of breast cancerDifferences in tissue stiffness have potential to aid in diagnosis, therapy